Cell Source, Inc. Debt Conversion, Converted Instrument, Amount
Cell Source, Inc. (CLCS) reported Debt Conversion, Converted Instrument, Amount of $1.55 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-12-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2022-12-02
- Cell Source, Inc. debt conversion, converted instrument, amount for the quarter ending 2022-06-30 was $114.47K.
- Cell Source, Inc. debt conversion, converted instrument, amount for the quarter ending 2022-03-31 was $1.43M.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month |
|---|---|---|---|
| 2022-06-30 | $114.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-02 | $1.55M 10-Q · filed 2022-12-02 | |
| 2022-03-31 | $1.43M 10-Q · filed 2022-11-02 | ||
| 2013-11-11 | $511.00K 10-K · filed 2015-03-13 |